How to Interpret EBV Serology
The key to interpreting EBV labs is understanding the pattern of three core antibodies: VCA IgM, VCA IgG, and EBNA IgG—their presence or absence defines the stage of infection. 1
Core Interpretation Framework
Primary (Acute) Infection
- VCA IgM positive (with or without VCA IgG)
- EBNA negative
This pattern indicates recent primary infection with EBV 1. The absence of EBNA antibodies is the critical distinguishing feature, as EBNA develops 1-2 months after primary infection and persists for life 1.
Past Infection
- VCA IgG positive
- VCA IgM negative
- EBNA positive
This is the most common pattern, seen in over 90% of adults 1. The presence of EBNA antibodies indicates infection occurred more than 6 weeks prior and therefore does not implicate EBV as a current cause of illness 1.
Seronegative (Never Infected)
- All antibodies negative
- Patient has never been exposed to EBV
Initial Testing Approach
Start with heterophile antibody testing (Monospot) for suspected acute mononucleosis 1. This becomes detectable between days 6-10 after symptom onset, peaks at weeks 2-3, and gradually declines over a year 1.
Important Caveats for Heterophile Testing:
- False negatives occur in ~10% of patients, especially common in children under 10 years 1
- False positives can occur with leukemia, pancreatic carcinoma, viral hepatitis, or CMV infection 1
When heterophile testing is negative but clinical suspicion remains high, proceed to VCA IgM/IgG and EBNA testing to differentiate EBV from other causes of mononucleosis-like illness (CMV, adenovirus, HIV, Toxoplasma) 1.
Atypical Patterns and Problem-Solving
Approximately 14-20% of serological patterns are atypical and require additional interpretation 2, 3:
Isolated VCA IgG Positive (Most Common Atypical Pattern)
This can represent:
- Very early acute infection (before VCA IgM appears)
- Late past infection (after VCA IgM has waned but before EBNA develops)
- Rare EBNA non-responders (5-10% of infected patients never develop EBNA antibodies) 1
Solution: Consider IgG avidity testing or follow-up serology in 2-4 weeks 4
All Three Antibodies Positive (VCA IgM + VCA IgG + EBNA)
This suggests:
- Recent infection (convalescent phase)
- Possible reactivation
Isolated EBNA Positive
Rare pattern requiring confirmation with repeat testing or alternative methods 4
Special Populations and Contexts
Immunocompromised Patients
In transplant recipients or patients with HIV/severe immunodeficiency, serology is unreliable. Instead:
- Use EBV viral load (quantitative PCR) in peripheral blood for monitoring 1
- Rising viral loads may precede EBV-associated lymphoproliferative disease 1
- Diagnosis of EBV-PTLD requires tissue biopsy demonstrating EBV DNA, RNA, or protein—blood PCR alone is insufficient 1, 5
Chronic Active EBV (CAEBV)
Suspect when patients have:
- Persistent/recurrent mononucleosis-like symptoms
- Unusual antibody pattern: markedly elevated VCA and EA antibodies (VCA-IgG ≥1:640, EA-IgG ≥1:160) 6
- Elevated EBV DNA in peripheral blood mononuclear cells (>10^2.5 copies/mg DNA) 6
Critical: CAEBV requires demonstration of EBV in affected tissues, not just elevated antibodies 6
Practical Algorithm
Clinical suspicion of acute mononucleosis → Order heterophile antibody (Monospot)
- If positive → Acute EBV infection confirmed
- If negative → Proceed to step 2
Heterophile negative or need to establish EBV status → Order VCA IgM, VCA IgG, EBNA IgG
- Apply core interpretation patterns above
- If atypical pattern → Consider follow-up testing in 2-4 weeks
Immunocompromised patients → Skip serology, order EBV quantitative PCR (viral load)
Suspected CAEBV or lymphoproliferative disease → Tissue biopsy with EBER in situ hybridization 5, 6
Common Pitfalls to Avoid
- Don't rely on serology alone in immunocompromised patients—they may not mount adequate antibody responses 1
- Don't diagnose EBV-PTLD based solely on positive blood PCR—tissue confirmation is mandatory 5
- Don't dismiss negative heterophile testing in children—proceed to specific EBV antibody testing 1
- Don't interpret isolated VCA IgG as definitively "past infection" without considering clinical context and timing 3, 4